In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aldagen, Inc.

http://www.aldagen.com

Latest From Aldagen, Inc.

Aldea raises $24m for alcohol detox, anemia drug

Aldea Pharmaceuticals will begin clinical trials in acute alcohol intoxication and Fanconi anemia for AD-6626, the company's lead drug candidate for aldehyde metabolism disorders, with $24m in Series B venture capital from new Russian and Chinese investors and existing US-based VC backers.

Metabolic Disorders Gastrointestinal

Stroke candidate to feel brunt of Cytomedix restructure

Cytomedix is to downsize its R&D activities in a renewed focus on profitability, in what is its second reorganization in as many months.

Dermatology Wound Healing & Tissue Repair

Cytomedix falls 25% as it turns to three-pronged financing plan

Cytomedix stock lost 25% of its value on 20 February when the Gaithersburg, Maryland-based company specializing in autologous regenerative therapies announced three different financing vehicles designed to generate up to $27.5 million for its "2013 operational business plan."

Dermatology Wound Healing & Tissue Repair

Deals Shaping The Medical Industry (03/2012)

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device
See All

Company Information

UsernamePublicRestriction

Register